There was no heterogeneity in the association of the PRS with CBC risk by age at first diagnosis, family history of breast cancer, radiation treatment, ER status of first breast cancer, PR status of first breast cancer, hormone replacement therapy at first breast cancer, age at menopause, or parity (Table 3). This evidence concerns the gene ESR1 and breast carcinoma.